US Army orders M1061 cartridges
Day and Zimmerman is to manufacture M1061 high-explosive cartridges for 60mm mortars, under a $92.7 million contract modification from the US Army.
Work will be performed in Parsons, Kansas, with an estimated completion date of 27 September 2021.
The M1061 was originally developed by Orbital ATK (now Northrop Grumman Innovation Systems), Saab Bofors Dynamics Switzerland, and the US Army Armament Research, Development and Engineering Center at the Picatinny Arsenal, New Jersey.
The cartridge was developed to increase the effectiveness of the 60mm mortar while improving its insensitive munitions characteristics. The increase in lethality (to near 81mm lethality) was accomplished by utilising a matrix comprised of pre-formed fragments and PBXN-110 explosive.
As part of our promise to deliver comprehensive coverage to our Defence Insight and Premium News subscribers, our curated defence news content provides the latest industry updates, contract awards and programme milestones.
More from Land Warfare
-
Laser weapon solutions are emerging as Europe confronts air defence cost imbalance
Europe’s air defence debate is increasingly shaped by the blunt economics of the field. While high-value interceptor missiles can effectively shoot down cheap drones, doing so at scale presents cost challenges.
-
ARX Robotics expands in UK following British Army backing for uncrewed platforms
Following an order from the British Army, ARX Robotics has begun manufacturing autonomous ground platforms in the UK. Christopher Foss examines the company's growing range of systems.
-
Textron unveils a smaller, low-cost variant of the Ripsaw family of UGVs
Ripsaw M1 has been designed to support the US Marine Corps’ littoral missions by carrying diverse types of payloads and performing multiple missions. Shephard spoke with Textron to find out more.
-
UK plans to adopt “phased approach to restarting” British Army Ajax programme
The introduction of Ajax vehicles into British Army service was stopped after health issues during an exercise. However, an investigation reported “no single causal mechanism of the symptoms reported by our soldiers but rather a combination of multiple factors”.